DE60325373D1 - Chimäres mhc-protein und oligomer davon - Google Patents

Chimäres mhc-protein und oligomer davon

Info

Publication number
DE60325373D1
DE60325373D1 DE60325373T DE60325373T DE60325373D1 DE 60325373 D1 DE60325373 D1 DE 60325373D1 DE 60325373 T DE60325373 T DE 60325373T DE 60325373 T DE60325373 T DE 60325373T DE 60325373 D1 DE60325373 D1 DE 60325373D1
Authority
DE
Germany
Prior art keywords
derived
section
oligomer
concerns
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325373T
Other languages
English (en)
Inventor
Nikolai Franz Schwabe
Tan Linda Cheng-Choo
Catherine Elizabeth Napper
Jeremy William Fry
Susan Pang
Rachel Kate Spooner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proimmune Ltd
Original Assignee
Proimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proimmune Ltd filed Critical Proimmune Ltd
Application granted granted Critical
Publication of DE60325373D1 publication Critical patent/DE60325373D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60325373T 2002-08-21 2003-08-14 Chimäres mhc-protein und oligomer davon Expired - Lifetime DE60325373D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0219459A GB2392158B (en) 2002-08-21 2002-08-21 Chimeric MHC protein and oligomer thereof
PCT/EP2003/009056 WO2004018520A1 (en) 2002-08-21 2003-08-14 Chimeric mhc protein and oligomer thereof

Publications (1)

Publication Number Publication Date
DE60325373D1 true DE60325373D1 (de) 2009-01-29

Family

ID=9942707

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325373T Expired - Lifetime DE60325373D1 (de) 2002-08-21 2003-08-14 Chimäres mhc-protein und oligomer davon

Country Status (11)

Country Link
US (2) US20040209295A1 (de)
EP (1) EP1530592B8 (de)
JP (1) JP4686187B2 (de)
CN (1) CN1708512A (de)
AT (1) ATE417861T1 (de)
AU (1) AU2003263221A1 (de)
CA (1) CA2493333C (de)
DE (1) DE60325373D1 (de)
DK (1) DK1530592T3 (de)
GB (1) GB2392158B (de)
WO (1) WO2004018520A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070771B1 (en) * 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
WO2009003492A1 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US7495090B2 (en) * 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
GB2408507B (en) * 2003-10-06 2005-12-14 Proimmune Ltd Chimeric MHC protein and oligomer thereof for specific targeting
GB2409456B (en) * 2003-10-30 2006-01-04 Proimmune Ltd Oligomeric receptor ligand pair member complexes
GB2422834B8 (en) * 2005-02-04 2007-01-04 Proimmune Ltd MHC oligomer and method of making the same
GB2424645B (en) 2005-04-01 2007-06-06 Proimmune Ltd Method of producing a set of MHC molecules
US8231872B2 (en) 2005-04-25 2012-07-31 The Trustees Of Dartmouth College Regulatory T cell mediator proteins and uses thereof
US20090061478A1 (en) * 2006-01-30 2009-03-05 Lene Have Poulsen High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
GB2442048B (en) * 2006-07-25 2009-09-30 Proimmune Ltd Biotinylated MHC complexes and their uses
EP2361930A3 (de) 2007-03-26 2011-10-26 Dako Denmark A/S Multimere von peptide-mhc komplexen und deren verwendung in borrelia infektionskrankheiten
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
EP2337795A2 (de) * 2008-10-01 2011-06-29 Dako Denmark A/S Mhc-multimere in krebsimpfstoffen und der untersuchung der immunreaktion
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
WO2010106770A1 (en) 2009-03-18 2010-09-23 Oncotherapy Science, Inc. Neil3 peptides and vaccines including the same
TWI507204B (zh) 2009-05-26 2015-11-11 Oncotherapy Science Inc Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
TW201136604A (en) 2009-12-14 2011-11-01 Oncotherapy Science Inc TMEM22 peptides and vaccines including the same
GB201002730D0 (en) * 2010-02-18 2010-04-07 Uni I Oslo Product
AU2011225577B2 (en) 2010-03-11 2017-01-19 Oncotherapy Science, Inc. HJURP peptides and vaccines including the same
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
NZ602634A (en) 2010-03-26 2015-06-26 Dartmouth College Vista regulatory t cell mediator protein, vista binding agents and use thereof
TW201627003A (zh) 2010-04-02 2016-08-01 腫瘤療法 科學股份有限公司 Ｅｃｔ２胜肽及含此胜肽之疫苗
WO2012122087A1 (en) * 2011-03-05 2012-09-13 Indiana University Research And Technology Corporation Epitope fluctuation and immunogenicity
UA114298C2 (uk) 2011-10-28 2017-05-25 Онкотерапі Саєнс, Інк. Пептид торк та вакцина, що його містить
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
EP2892558B1 (de) 2012-09-07 2019-04-10 The Trustees Of Dartmouth College Vista-modulatoren zur diagnose und behandlung von krebs
EP3677310A1 (de) 2012-10-08 2020-07-08 St. Jude Children's Research Hospital Therapien auf der basis der steuerung der stabilität und funktion regulatorischer t-zellen über eine neuropilin-1:semaphorin-achse
TWI658049B (zh) 2013-03-12 2019-05-01 腫瘤療法 科學股份有限公司 Ｋｎｔｃ２胜肽及含此胜肽之疫苗
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
JP6590810B2 (ja) 2013-12-24 2019-10-16 ヤンセン ファーマシューティカ エヌブイ 抗ｖｉｓｔａ抗体および断片
MX2016016310A (es) 2014-06-11 2017-10-20 A Green Kathy Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
US11585806B2 (en) 2014-06-13 2023-02-21 Immudex Aps General detection and isolation of specific cells by binding of labeled molecules
MX2017007136A (es) 2014-12-05 2017-12-04 Immunext Inc Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
JP7026509B2 (ja) 2015-06-24 2022-02-28 ヤンセン ファーマシューティカ エヌブイ 抗ｖｉｓｔａ抗体およびフラグメント
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
TW202216201A (zh) 2016-02-12 2022-05-01 比利時商楊森製藥公司 抗vista抗體及片段、其用途及鑑定其之方法
RU2021111187A (ru) 2016-04-15 2021-04-29 Янссен Фармасьютикалз, Инк. Антитела против человеческого vista и их применение
MA45738A (fr) 2016-07-13 2019-05-22 Harvard College Échafaudages mimétiques de cellules présentant l'antigène et procédés pour les préparer et les utiliser
US10294454B2 (en) 2016-08-24 2019-05-21 General Electric Company Methods and kits for cell activation
EP3509629A1 (de) 2016-09-06 2019-07-17 H. Hoffnabb-La Roche Ag Mhc-gebundene peptid-arrays und verfahren zur verwendung davon
CN111032850A (zh) 2017-04-27 2020-04-17 朱诺治疗学有限公司 寡聚粒子试剂及其使用方法
MX2019015769A (es) * 2017-06-23 2020-08-03 Verimmune Inc Partículas tipo virus quiméricas y usos de estas como redireccionadores de respuestas inmunitarias específicos para el antígeno.
US20220387605A1 (en) * 2017-07-18 2022-12-08 Duke University Compositions and methods comprising self-assembling peptide-polymer nanofibers for sublingual immunization
EP3898666A2 (de) 2018-12-17 2021-10-27 Immudex ApS Panel mit borrelia-mhc-multimeren
EP3902527A4 (de) 2018-12-27 2022-09-28 VerImmune Inc. Konjugierte virusähnliche partikel und verwendungen davon als anti-tumor-immunumlenker
EP4078178A1 (de) 2019-12-20 2022-10-26 Miltenyi Biotec B.V. & Co. KG Reversible zelldetektion über mhc mit konjugaten mit einer enzymatisch spaltbaren detektionseinheit
AU2021364548A1 (en) 2020-10-19 2023-06-08 Verimmune Inc. Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer
WO2022109339A1 (en) 2020-11-20 2022-05-27 Becton, Dickinson And Company Use of dextramer in single cell analysis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2221065T3 (es) * 1996-08-16 2004-12-16 The President And Fellows Of Harvard College Proteinas de fusion de clase ii del mhc, solubles, monovalentes o polivalentes, y sus usos.
US20050003431A1 (en) * 1996-08-16 2005-01-06 Wucherpfennig Kai W. Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
CA2321262A1 (en) * 1998-02-19 1999-08-26 President And Fellows Of Harvard College Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor
WO2000044908A2 (en) * 1999-02-01 2000-08-03 Beth Israel Deaconess Medical Center Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins
JP2004524019A (ja) * 2001-01-12 2004-08-12 ベクトン・ディキンソン・アンド・カンパニー 内因性蛍光自己多量体化ｍｈｃ融合タンパク質およびその複合体
US20020082411A1 (en) * 2001-01-23 2002-06-27 Darrick Carter Immune mediators and related methods
GB2408507B (en) * 2003-10-06 2005-12-14 Proimmune Ltd Chimeric MHC protein and oligomer thereof for specific targeting
GB2409456B (en) * 2003-10-30 2006-01-04 Proimmune Ltd Oligomeric receptor ligand pair member complexes

Also Published As

Publication number Publication date
GB0219459D0 (en) 2002-09-25
ATE417861T1 (de) 2009-01-15
CA2493333A1 (en) 2004-03-04
CA2493333C (en) 2015-11-24
EP1530592B1 (de) 2008-12-17
WO2004018520A1 (en) 2004-03-04
EP1530592B8 (de) 2009-03-25
US20090137472A1 (en) 2009-05-28
GB2392158B (en) 2005-02-16
US20040209295A1 (en) 2004-10-21
CN1708512A (zh) 2005-12-14
GB2392158A (en) 2004-02-25
EP1530592A1 (de) 2005-05-18
JP4686187B2 (ja) 2011-05-18
JP2006516882A (ja) 2006-07-13
DK1530592T3 (da) 2009-03-30
AU2003263221A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
DE60325373D1 (de) Chimäres mhc-protein und oligomer davon
US11873483B2 (en) Proteomic analysis with nucleic acid identifiers
AU761985B2 (en) In vitro selection and optional identification of polypeptides using solid support carriers
DK1392359T4 (da) Specifikke bindingsproteiner og deres anvendelser.
WO2000023593A3 (en) Molecular pathogenicide mediated plant disease resistance
Bertschinger et al. Selection of single domain binding proteins by covalent DNA display
DK0898618T3 (da) Fremgangsmåde til tilvejebringelse af hidtil ukendte DNA-sekvenser
CN113302491A (zh) pMHC占有率的链霉亲和素-寡核苷酸缀合物的组成
Kojima et al. High-throughput screening of DNA binding sites for transcription factor AmyR from Aspergillus nidulans using DNA beads display system
JP2017160272A (ja) アゾリン化合物及びアゾール化合物のライブラリー、並びにその製造方法
WO2002033084A3 (en) Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
Hinz et al. Simplifying the detection of surface presentation levels in yeast surface display by intracellular tGFP Expression
DE50210523D1 (de) Verfahren zur identifizierung von zielepitopen der t-zell-vermittelten immunantwort und zum nachweis epitop-spezifischer t-zellen
WO2004058181A3 (en) Vmp-like sequences of pathogenic borrelia species and strains
CN112083172A (zh) 一种从蜱cDNA文库中筛选具有抗凝血活性的蛋白质的方法
Butera et al. Cloning, expression, and characterization of a bi-functional disintegrin/alkaline phosphatase hybrid protein
Becker et al. The origin and evolution of the plant cell surface: algal integrin-associated proteins and a new family of integrin-like cytoskeleton-ECM linker proteins
US20230287490A1 (en) Systems and methods for assaying a plurality of polypeptides
WO2002074930A3 (en) Trans inteins for protein domain shuffling and biopolymerization
JP6341909B2 (ja) Ｓｅｏ−ｆ融合タンパク質を含む人工フォリソーム体、このタンパク質をコードするベクターを含む植物細胞又は酵母細胞、及びｓｅｏ−ｆ融合タンパク質をコードするベクター
JP2019523646A (ja) 経路決定の方法、組成物、およびその使用
Galkin et al. Increasing of the expression of recombinant scFv-antibodies efficiency
JPH11287804A (ja) 免疫測定試薬の製造方法、免疫測定試薬及び免疫測定方法
CA2415253A1 (en) Bio-probes and use thereof
Fitzgerald Immuno-PCR detection of custom protein targets using recombinant binding molecules specifically conjugated to DNA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition